Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | ap endonuclease, putative | 0.0021 | 0 | 0.5 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0021 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0039 | 1 | 1 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0021 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0039 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0021 | 0 | 0.5 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0021 | 0 | 0.5 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0021 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0039 | 1 | 1 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0021 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0039 | 1 | 1 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0021 | 0 | 0.5 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0039 | 1 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0039 | 1 | 1 |
Toxoplasma gondii | exonuclease III APE | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0021 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0021 | 0 | 0.5 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0021 | 0 | 0.5 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0039 | 1 | 1 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0021 | 0 | 0.5 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0021 | 0 | 0.5 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0021 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0039 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ED50 (functional) | = 73 mg kg-1 | Antibacterial activity againist E. coli 120 infected NMRI mice after peroral administration | ChEMBL. | 6379179 |
ED50 (functional) | = 73 mg kg-1 | Antibacterial activity againist E. coli 120 infected NMRI mice after peroral administration | ChEMBL. | 6379179 |
MIC (functional) | = 1.25 ug ml-1 | Minimum inhibitory concentration of compound against Klebsiella pneumoniae delta 217 | ChEMBL. | 6379179 |
MIC (functional) | = 1.56 ug ml-1 | Minimum inhibitory concentration against Proteus mirabilis delta 89 | ChEMBL. | 6379179 |
MIC (functional) | = 2 ug ml-1 | Minimum inhibitory concentration of compound against Neisseria gonorrhoeae AS 7720 | ChEMBL. | 6379179 |
MIC (functional) | = 2 ug ml-1 | Minimum inhibitory concentration of compound against Neisseria gonorrhoeae W2 | ChEMBL. | 6379179 |
MIC (functional) | = 2.5 ug ml-1 | Minimum inhibitory concentration of compound against Salmonella typhimurium delta 119 | ChEMBL. | 6379179 |
MIC (functional) | = 6.25 ug ml-1 | Minimum inhibitory concentration of compound against Escherichia coli delta 120 | ChEMBL. | 6379179 |
MIC (functional) | = 6.25 ug ml-1 | Minimum inhibitory concentration of compound against Escherichia coli delta 120 | ChEMBL. | 6379179 |
MIC (functional) | = 10 ug ml-1 | Minimum inhibitory concentration of compound against E. aerogenes delta 220 | ChEMBL. | 6379179 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.